Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06543849
NA

The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients

Sponsor: Tang Ziren

View on ClinicalTrials.gov

Summary

This study will be a single-center, prospective, randomized controlled trial with an estimated sample size of 64 patients. Eligible patients will be randomly assigned in a 1:1 ratio to receive TTM for either 24 hours or 72 hours. The primary outcome measure will be the changes in thrombin function indices at various time points during TTM treatment in both groups. The secondary endpoints of the study include additional coagulation function indicators, the incidence of bleeding-related events between the two groups, the amount of blood products used, the incidence of thrombotic events, and the CPC scores at 28 days and 6 months for both groups.

Official title: The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients (ITTC Trial): A Single-Center, Prospective, Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2024-12-01

Completion Date

2025-12-31

Last Updated

2025-04-11

Healthy Volunteers

No

Interventions

PROCEDURE

Target Temperature Management Treatment

Target Temperature Management Treatment

Locations (1)

Beijing chao-yang Hospital, Capital Medical University

Beijing, Beijing Municipality, China